Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06000410 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
A Phase 3 study, sponsored by Organogenesis.
- Completed
- Registry status
- Phase 3
- Development phase
- 594
- Enrollment target
NCT06000410 is a Phase 3 study that has completed, run by Organogenesis. The registered enrollment target is 594 participants.
The verdict
NCT06000410, a Phase 3 study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 594 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.
Interventions
- DRUG Placebo
- BIOLOGICAL Amniotic Suspension Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2025-11-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06000410
The ClinicalTrials.gov registry entry for NCT06000410 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06000410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06000410 about?
NCT06000410 is a clinical study titled "A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee". This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.
What is the current status of trial NCT06000410?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 594 participants. The study started on 2023-09-06. Estimated completion is 2025-11-30.
What interventions are being tested in trial NCT06000410?
The interventions under investigation include: Placebo (DRUG), Amniotic Suspension Allograft (BIOLOGICAL).
Who is sponsoring clinical trial NCT06000410?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.